Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Is AstraZeneca plc Overvalued?

| Rupert Hargreaves

AstraZeneca plc (LON: AZN) is one of the most expensive stocks around but is it worth it.

Read more »

Investing Articles

3 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and Dechra Pharmaceuticals plc

| Kevin Godbold

Shire PLC (LON:SHP), BTG plc (LON:BTG) and Dechra Pharmaceuticals plc (LON:DPH) could boost your 2015 returns

Read more »

Investing Articles

5 Stunning Pharma Stocks: GlaxoSmithKline plc, AstraZeneca plc, Shire PLC, BTG plc & Hikma Pharmaceuticals Plc

| Peter Stephens

These 5 pharma stocks could be worth buying right now: GlaxoSmithKline plc (LON:GSK), AstraZeneca plc (LON:AZN), Shire PLC (LON:SHP), BTG…

Read more »

Investing Articles

Will Shire PLC Acquisition Help It Beat GlaxoSmithKline plc And AstraZeneca plc?

| Alan Oscroft

Is Shire PLC (LON: SHP) setting its sights on GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

AstraZeneca plc, GlaxoSmithKline plc And Shire PLC Are Set For A Decade Of Rapid Growth

| Rupert Hargreaves

AstraZeneca plc (LON: AZN), GlaxoSmithKline plc (LON: GSK) and Shire PLC (LON: SHP) are set for rapid growth as sales explode.

Read more »

Investing Articles

Will Hikma Pharmaceuticals Plc Beat GlaxoSmithKline plc And AstraZeneca plc Again In 2015?

| Alan Oscroft

While GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: ASN) have had a tough time, Hikma Pharmaceuticals Plc (LON: HIK)…

Read more »

Investing Articles

Why I Think Shire plc Will Outperform AstraZeneca plc And GlaxoSmithKline plc By At Least 10% In 2015

| Alessandro Pasetti

Alessandro Pasetti explains why Shire plc (LON:SHP) is his favourite pick, followed by GlaxoSmithKline plc (LON:GSK), and why he'd avoid…

Read more »

Investing Articles

How GlaxoSmithKline PLC And AstraZeneca PLC Will Fare In 2015

| Prabhat Sakya

Are GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN) buys in 2015?

Read more »

Investing Articles

Will Dividends At AstraZeneca plc Really Outstrip The Market In 2015?

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN) could be considered a perilous dividend pick.

Read more »

Investing Articles

How Will GlaxoSmithKline plc, AstraZeneca plc And Shire PLC Fare During 2015?

| Kevin Godbold

After the collapse of supermarket shares, will GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN) and Shire plc (LON: SHP)…

Read more »

Investing Articles

Will Crowd Sourcing Help AstraZeneca plc And GlaxoSmithKline plc Rekindle Growth?

| Rupert Hargreaves

 AstraZeneca plc (LON:AZN) and GlaxoSmithKline plc (LON: GSK) are pooling their resources to try and restart growth.

Read more »

Investing Articles

Why AstraZeneca plc, NEXT plc and United Utilities Group PLC Are In The Top 10 For 2014

| Alan Oscroft

AstraZeneca plc (LON: AZN), NEXT plc (LON: NXT) and United Utilities Group PLC (LON: UU) have soared this year.

Read more »